Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.
Evolent Health reports developments tied to its healthcare services business for people with complex conditions. Company news commonly covers operating and financial results, customer activity with health plans and providers, and the Performance Suite contract model used in its specialty care operations.
Recurring updates also include Evolent's complex specialty care focus in oncology, cardiology and musculoskeletal conditions, management participation in healthcare investor conferences, leadership appointments, board and compensation matters, and equity-award disclosures under NYSE rules.
Evolent Health (NYSE: EVH) will have CEO Seth Blackley and CFO John Johnson present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021, at 12:00 p.m. ET. A live webcast of the event will be available on Evolent's investor relations website. Evolent Health specializes in delivering clinical and administrative solutions to enhance healthcare affordability and manage total costs. The company has received the Population Health Program Accreditation and is recognized as a leader in healthcare service delivery.
Evolent Health (NYSE: EVH) will announce its second quarter 2021 operating results on August 4, 2021, after the market closes. A conference call will take place at 6:00 p.m. Eastern Time the same day, allowing shareholders to participate via phone. Evolent Health specializes in clinical and administrative healthcare solutions aimed at improving total care management. The company has achieved notable accreditations and is recognized for its workplace culture.
Summary not available.
Evolent Health (NYSE: EVH) has announced that CEO Seth Blackley and CFO John Johnson will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021, at 5:30 p.m. ET. The event will feature a live webcast available on Evolent's investor relations website. Evolent Health provides clinical and administrative solutions aimed at improving health care affordability and simplicity for payers and providers, serving a national client base and recognized for its quality and workplace culture.
Evolent Health, Inc. (EVH) reported Q1 2021 GAAP revenue of $215.1 million, down from $221.2 million in Q1 2020. The net loss attributable to shareholders improved significantly to $(9.8 million), compared to $(78.8 million) in the prior year. Adjusted EBITDA was $14.9 million, a notable increase from $3.9 million in Q1 2020. With approximately 11.6 million lives managed, the company announced new partnerships aimed at expanding services in oncology and cardiology. CEO Seth Blackley emphasized strong demand for their solutions and targeted mid-teens organic growth.
Evolent Health, Inc. (EVH) reported a GAAP revenue of $215.1 million for Q1 2021, marking a decrease from $221.2 million in Q1 2020. The company achieved an Adjusted EBITDA of $14.9 million, up from $3.9 million year-on-year. A net loss attributable to shareholders was $(9.8) million, an improvement from $(78.8) million in 2020. Evolent is managing approximately 11.6 million lives and has announced new partnerships to enhance its service offerings. CEO Seth Blackley expressed optimism about the company's trajectory towards organic growth and margin expansion.
Evolent Health, listed on NYSE as EVH, announced its participation in the 2021 Bank of America Health Care Conference. Scheduled for May 13, 2021, at 2:00 p.m. ET, CEO Seth Blackley and CFO John Johnson will present. Investors can access a live webcast on the company's investor relations page. Evolent Health specializes in clinical and administrative solutions aimed at improving health care efficiency and affordability, serving a diverse range of payers and providers nationally.
Evolent Health (NYSE: EVH) will announce its first quarter 2021 operating results on May 5, 2021, after market close. A conference call is scheduled for 6:00 p.m. Eastern Time, where shareholders can participate by dialing 855.940.9467 or 412.317.6034 for international callers. An audio playback will be accessible on Evolent's investor relations website for one week post-call.
Evolent offers clinical and administrative solutions aimed at enhancing healthcare affordability and efficiency, serving a national client base of payers and providers.
Evolent Health is launching a Covid-19 vaccine video education program in partnership with various Black community leaders at Quinn Chapel AME in Chicago. This initiative aims to reach up to 1 million Black and Latinx congregants over Easter weekend, addressing vaccine myths and encouraging vaccinations. The program will feature personal stories from faith leaders and will be shared across 500 faith communities. Evolent has a history of supporting local health initiatives and aims to bridge care gaps exacerbated by the pandemic.
Evolent Health (NYSE: EVH) reported 40% growth in the population served by its Evolent Care Partners network compared to 2020. Key drivers include new partnerships, regional expansion in Texas, and growth with existing partners. The network now consists of ~500 primary care physicians, a 30% increase from last year, managing approximately 90,000 lives under Medicare Advantage and Commercial plans, equating to about $900M in premium equivalent. The company emphasizes its innovative technology and clinical programs that improve care coordination and cost management, even during the pandemic.